Updated:
Polysoar
Beijing Polysoar Xiangyuan Investment Co., founded in 2014, operates as a domestic investment service and advisory firm that channels capital from...
Polysoar
Beijing Polysoar Xiangyuan Investment Co., founded in 2014, operates as a domestic investment service and advisory firm that channels capital from high-net-worth individuals into China’s technology and manufacturing ecosystem. The firm identifies itself as the elective vehicle of seasoned shareholders including Gage Capital and Hong Kong Kunlun Group, leveraging their combined balance sheets and origination networks to access late-stage and pre-IPO opportunities. Polysoar’s deployment spans equity investments, strategic mergers, alternative assets, and overseas allocations, with a portfolio exceeding 120 companies. Its stated deal footprint covers China, North America, Africa, and Europe. The firm highlights direct exposure to semiconductor packaging and testing via PCM (Suzhou) Technology, advanced chip design through Moore Threads and Muxi Technology, humanoid robotics via Ubtech Robotics — which listed on the Hong Kong Stock Exchange — and healthcare manufacturing through HEC Pharm. A ¥22 billion deployment figure is published on the firm’s website without independent audit verification. With a research and advisory team of over 300, Polysoar reports more than 30 completed exits from a project pipeline that once numbered 90 active engagements. The firm runs a club-style investor network called Wanbaohui and a media program titled Exploring Unicorns, both designed to funnel deal flow and brand visibility among China’s growing private-wealth audience. As of 2025, the most active window of public disclosure covers the 2023–2024 IPO wave of its portfolio companies, including the Shanghai STAR Market listings of Moore Threads and Muxi Technology. Polysoar’s structural distinction lies in its function as a retail-feeder platform rather than a proprietary private-equity manager: it aggregates individual investor capital into fund-of-funds and single-deal SPVs, then places it alongside institutional shareholders like Gage Capital. This creates a hybrid origination model where deal access depends on shareholder relationships, while distribution relies on a direct-to-investor service model uncommon among China’s institutionally oriented asset managers.
General information
Firm type
Bank / Wealth / Trust
Year founded
2014
AUM
Undisclosed
Location
Region
Asia
Country
China
City
Beijing
Corporate office
Beijing, China
Sector focus
Frequently asked questions
How does Polysoar source its investment opportunities?
Polysoar relies on its shareholder relationships — notably Gage Capital and Hong Kong Kunlun Group — for deal origination. The firm’s website describes their role as providing “equity empowerment” and institutional backing, which grants Polysoar access to pre-IPO rounds of technology companies such as Ubtech Robotics and Moore Threads. It then distributes these opportunities to its own network of high-net-worth clients.
What is Polysoar’s relationship with Gage Capital?
Gage Capital is described by Polysoar as a foundational shareholder that provides capital and deal-flow support. The two firms share investment service verticals and co-brand certain honors and events, though Polysoar operates under its own Beijing-headquartered entity. The exact ownership or control relationship is not publicly detailed beyond the “资深股东” (senior shareholder) designation.
Does Polysoar make direct investments or only offer fund-of-funds products?
Polysoar provides a mix of direct equity investment services, FOF advisory, and single-deal co-investment structures. The firm’s materials list equity investment services alongside FOF investment advisory as separate service lines, and its portfolio roster includes direct named positions in companies like PCM and HEC Pharm.
What types of clients does Polysoar serve?
Polysoar exclusively targets high-net-worth individual investors, describing its core activity as providing “one-stop, comprehensive asset allocation services” to that demographic. The firm does not report serving institutional limited partners such as pension funds, endowments, or sovereign wealth funds.
Which sectors does Polysoar invest in?
Polysoar concentrates on semiconductors, artificial intelligence and robotics, healthcare, and consumer products. Its website showcases semiconductor packaging firm PCM, AI chip designers Moore Threads and Muxi Technology, humanoid robotics company Ubtech Robotics, pharmaceutical manufacturer HEC Pharm, and consumer goods company China Resources Beverages.
What is the scale of Polysoar’s investment activity?
Polysoar reports a total deployment of approximately ¥22 billion across over 120 projects, with more than 30 exits completed. The firm employs a research and service team of over 300, though it is not registered as an asset manager with a publicly disclosed AUM figure.
Does Polysoar invest outside of China?
Polysoar states that its investment footprint includes North America, Africa, and Europe, alongside its domestic Chinese activity. However, all named portfolio companies in its public materials are China-domiciled, and the firm does not detail specific non-Chinese transactions.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: